Article

Incidental Uptake of 68Ga-DOTA-IBA in Prostate Adenocarcinoma

Huipan LiuDepartment of Nuclear Medicine, The Affiliated HospitalYuhong LiuFeifan XiangDepartment of Nuclear Medicine, The Affiliated HospitalJianwen ZhangYue ChenDepartment of Nuclear Medicine, The Affiliated Hospital

Clinical Nuclear Medicinejournal2024en

ABI

Abstract

ABSTRACT: 68 Ga-labeled DOTA-ibandronic acid ( 68 Ga-DOTA-IBA) is a novel PET agent developed for bone tumors. In addition, 68 Ga-DOTA-IBA uptake in nonosseous findings has also been reported. Herein, we present a case of 68 Ga-DOTA-IBA uptake in primary prostate adenocarcinoma.

Topics

Prostate Cancer Treatment and Research Radiopharmaceutical Chemistry and Applications Peptidase Inhibition and Analysis

Identifiers

DOI: 10.1097/rlu.0000000000005415

Citations and references

Cited by 010 references

Metrics — AkademScholar · Coming soon